Drug firm Wockhardt has reported a consolidated net profit of Rs 334.76 crore for the fourth quarter ended March 31, 2013, mainly on back of robust sales. It had posted a net loss of Rs 191.64 crore for the corresponding period the previous financial year.
Consolidated
net sales of the company stood at Rs 1,485.50 crore for the quarter under consideration, against Rs 1,175.60 crore for the same period a year ago.
In a separate filing to Bombay Stock Exchange (BSE), the company said its board has "recommended dividend at the rate of 0.01 per cent (Rs 0.0005 per preference share of Rs 5 each) absorbing a sum of Rs 2,98,557 on 475,659,941 non-convertible cumulative redeemable preference shares of Rs 5 each and 121,454,927 optionally convertible cumulative redeemable preference shares of Rs 5 each."
Consolidated net profit for the 2012-13 financial year stood at Rs 1,594.12 crore, against Rs 342.71 crore for the previous financial year. Corresponding net sales of the company rose to Rs 5,609.42 crore for the fiscal year ended March 31, from Rs 4,350.50 crore for the earlier financial year.
Shares of Wockhardt closed 3.89 per cent higher at the Bombay Stock Exchange at Rs 1,227.50.
With inputs from PTI 
Special 
